Skip to contentPolaris Venture Partners V, L.P. — ACTELIS NETWORKS INC insider: 101 transactions · InsiderLensPolaris Venture Partners V, L.P.
- 10% owner at INTERNET BRANDS, INC. · on record since Jul 10, 2008
- 10% owner at FATE THERAPEUTICS INC · on record since Sep 30, 2013
- 10% owner at BIND Therapeutics, Inc · on record since Sep 27, 2013
- 10% owner at TREVENA INC · on record since Jan 30, 2014
- 10% owner at GENOCEA BIOSCIENCES, INC. · on record since Feb 11, 2014
- 10% owner at Cerulean Pharma Inc. · on record since Apr 15, 2014
- 10% owner at OCULAR THERAPEUTIX, INC · on record since Jul 31, 2014
- 10% owner at T2 Biosystems, Inc. · on record since Aug 14, 2014
- 10% owner at Ruthigen, Inc. · on record since Jun 25, 2015
- 10% owner at Lifeline Systems, Inc. · on record since May 14, 2015
- 10% owner at Cartesian Therapeutics, Inc. · on record since Jun 29, 2016
- 10% owner at Kala Pharmaceuticals, Inc. · on record since Jul 19, 2017
- 10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
- 10% owner at Cardlytics, Inc. · on record since Feb 15, 2018
- Director at Cardlytics, Inc. · on record since Aug 9, 2018
- 10% owner at Phreesia, Inc. · on record since Jul 24, 2019
- 10% owner at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
- See Remarks at ALLIED DEFENSE GROUP INC · on record since Mar 30, 2022
Insider trading activity of Polaris Venture Partners V, L.P.
- Transactions on record
- 101
- since Aug 12, 2014
- Open-market buys
- 8
- $5.5M
- Open-market sells
- 47
- $6M
- Companies traded
- 5
- last filing Sep 14, 2018
Figures computed from official regulatory filings — methodology.
Companies where Polaris Venture Partners V, L.P. has traded
Track record of Polaris Venture Partners V, L.P.
Statistical track record
Free- Open-market buys
- 8
- Last buy
- Nov 20, 2017
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Polaris Venture Partners V, L.P.
Co-insiders of Polaris Venture Partners V, L.P.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
BIND Therapeutics, Inc +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Sep 14, 2018 | Sell | -891 | 25.52 USD | $22.7K | SEC |
| Sep 14, 2018 | Sell | -26 | 26.41 USD | $686.7 | SEC |
| Sep 14, 2018 | Sell | -518 | 24.67 USD | $12.8K | SEC |
| Sep 14, 2018 | Sell | -143 | 25.19 USD | $3.6K | SEC |
| Sep 14, 2018 | Sell | -45,743 | 25.52 USD | $1.2M | SEC |
| Sep 14, 2018 | Sell | -205 | 25.19 USD | $5.2K | SEC |
| Sep 14, 2018 | Sell | -456 | 25.52 USD | $11.6K | SEC |
| Sep 14, 2018 | Sell | -404 | 25.19 USD | $10.2K | SEC |
| Sep 14, 2018 | Sell | -17 | 26.42 USD | $449.1 | SEC |
| Sep 14, 2018 | Sell | -49 | 26.41 USD | $1.3K | SEC |
| Sep 14, 2018 | Sell | -2,504 | 26.41 USD | $66.1K | SEC |
| Sep 14, 2018 | Sell | -1,477 | 24.67 USD | $36.4K | SEC |
| Sep 14, 2018 | Sell | -20,688 | 25.19 USD | $521.1K | SEC |
| Sep 14, 2018 | Sell | -314 | 25.52 USD | $8K | SEC |
| Sep 14, 2018 | Sell | -75,805 | 24.67 USD | $1.9M | SEC |
| Sep 14, 2018 | Sell | -760 | 24.67 USD | $18.7K | SEC |
| Nov 20, 2017 | Other | 1,102 | — | — | SEC |
| Nov 20, 2017 | Buy | 482,467 | 10.00 USD | $4.8M | SEC |
| Nov 20, 2017 | OtherD | -41,976 | 0.00 USD | $0 | SEC |
| Nov 20, 2017 | OtherD | -4,659 | 0.00 USD | $0 | SEC |
| Nov 20, 2017 | Other | 4,322 | — | — | SEC |
| Nov 20, 2017 | OtherD | -13,854 | 0.00 USD | $0 | SEC |
| Nov 20, 2017 | OtherD | -221,638 | 0.00 USD | $0 | SEC |
| Nov 20, 2017 | Other | 3,173 | — | — | SEC |
| Nov 20, 2017 | OtherD | -14,752 | 0.00 USD | $0 | SEC |